Non-Maleficence as a Fundamental Ethical Barrier to Euthanasia Legalization: A Critical Analysis
Central European Theological Review · 2025
DOI: 10.63154/cetr2025.2.4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Central European Theological Review, 2025. Verfasst von Tadej Strehovec.
Abstract (Originalsprache)
This paper explores non-maleficence as a key moral ground against euthanasia and assisted suicide legalization. Applying critical approaches to foundational bioethics literature, medical professions’ stances, and empirical knowledge from jurisdictions with legalized euthanasia, this paper indicates that physician participation in intentional death is in direct violation of the “do no harm” principle that characterizes medical practice. Slovenia’s 2025 legalization offers today’s context for thinking through how non-maleficence acts as a moral safeguard against the shift in medicine from healer to death-dispensing profession. The case analysis shows that the empirical findings in Belgium, the Netherlands, and Canada support slippery slope concerns about medicine—a concern that has been shown to threaten vulnerable populations with increased risks when euthanasia becomes medicalized. The paper argues that non-maleficence is the most important ethical principle to oppose euthanasia legalization as it preserves professional medical integrity and human dignity.
Zitieren
APA
Strehovec, T. (2025). Non-Maleficence as a Fundamental Ethical Barrier to Euthanasia Legalization: A Critical Analysis. Central European Theological Review. https://doi.org/10.63154/cetr2025.2.4
Vancouver
Strehovec T. Non-Maleficence as a Fundamental Ethical Barrier to Euthanasia Legalization: A Critical Analysis. Central European Theological Review. 2025. doi:10.63154/cetr2025.2.4
BibTeX
@article{Strehovec2025,
author = {Strehovec, Tadej},
title = {Non-Maleficence as a Fundamental Ethical Barrier to Euthanasia Legalization: A Critical Analysis},
journal = {Central European Theological Review},
year = {2025},
doi = {10.63154/cetr2025.2.4}
}
EUVIMED